Carson Wealth (CWM LLC)’s ADC Therapeutics ADCT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.9K	Sell	10,362 -8	-0.1%	-$32	﹤0.01%	3981
2025 Q4	$37K	Buy	10,370 +331	+3%	+$1.34K	﹤0.01%	3810
2025 Q3	$40K	Buy	10,039 +58	+0.6%	+$183	﹤0.01%	3694
2025 Q2	$27K	Sell	9,981 -3,330	-25%	-$7K	﹤0.01%	3704
2025 Q1	$19K	Buy	13,311 +13,291	+66,455%	+$22.6K	﹤0.01%	3691
2024 Q4	$0	Sell	20 -4	-17%	-$10	﹤0.01%	4878
2024 Q3	$0	Buy	+24	New	+$76	﹤0.01%	4788
2022 Q2	–	Sell	-950	Closed	-$14K	–	3743
2022 Q1	$14K	Hold	950	–	–	﹤0.01%	2277
2021 Q4	$19K	Buy	+950	New	+$22.9K	﹤0.01%	2007

Other funds holding ADCT

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ADCT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its ADC Therapeutics (ADCT) stake by 0.08% in Q1 2026, selling an estimated $32 and leaving 10,362 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3981.

Carson Wealth (CWM LLC) first reported a position in ADCT in Q4 2021 and has held it in 9 quarters since. The position peaked at $40K in Q3 2025. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

Carson Wealth (CWM LLC) held 10,362 shares of ADC Therapeutics worth $38.9K as of Q1 2026.
Carson Wealth (CWM LLC) sold 8 ADC Therapeutics shares in Q1 2026, an estimated $32.
ADC Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3981 holding.
Carson Wealth (CWM LLC) first reported a position in ADC Therapeutics in Q4 2021 and has held it in 9 quarters since.
Carson Wealth (CWM LLC)'s ADC Therapeutics position peaked at $40K in Q3 2025.
118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.